About Admeritox
Services
Preclinical Strategy
Preclinical Studies
Preclinical Evaluation
Benefits
Products & Therapeutic Areas
 
Downloads
admeritox.doc
admeritox.pdf
 
Useful Links
Contact
Homepage
 
 
 
 
 
 
 
 
 
 
 
 
 
   


SERVICES


ADMERITOX provides strategic and operational support in preclinical development of medicinal products, as well as support in the assessment of data and their presentation.

This support is reflected in the following services:

  • analysis of / advice on development plans
  • monitoring of toxicology, ADME and safety pharmacology studies
  • scientific writing or review of
    • study reports
    • publications
    • position papers
    • preclinical parts of documents for regulatory submission


ADMERITOX has worked with international and multidisciplinary teams of various small and medium-sized pharmaceutical companies. Services provided since its start in 2004 are summarized in the figure below:

     
GA / NDP:   gap analysis / nonclinical development plans
SA:   strategic advice
BP:   briefing package
SM:   study monitoring
SR:   study reports
IB / IMPD:   Investigator's Brochure / Investigational Medicinal Product Dossier
CTD:   Common Technical Document modules 2.6 and/or 2.4
SE:   safety evaluations
RQ:   regulatory questions